Previous 10 | Next 10 |
Montrouge, France, June 2, 2020 DBV Technologies To Present at the Goldman Sachs 41 st Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced th...
ShiftPixy PIXY -27% after pricing ~$12M public offering. More news on: GigaMedia Limited, Renren Inc., DBV Technologies S.A., Stocks on the move, , Read more ...
Gainers: Nano Dimension NNDM +272% . More news on: ShiftPixy, Inc., Mercurity Fintech Holding Inc., Iterum Therapeutics plc, Stocks on the move, , Read more ...
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 ...
COVID-19 Is Distracting Investors from an Amazing Market Opportunity While the world remains hyper-focused on COVID-19 as the biggest healthcare challenge of the past century, it is perhaps easy to overlook progress being made to treat more mundane (yet far more durable) medical problems. ...
DBVT Technologies (NASDAQ: DBVT ) files an offer to sell ordinary shares of an indeterminate amount. More news on: DBV Technologies S.A., Tech stocks news, , Read more ...
Montrouge, France, April 30, 2020 DBV Technologies Reports March 31, 2020 Cash Position DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its cash and cash equivalents and its n...
LMP Automotive Holdings (NASDAQ: LMPX ) +35% . More news on: LMP Automotive Holdings, Inc., AgEagle Aerial Systems, Inc., Soligenix, Inc., Stocks on the move, , Read more ...
Aimmune Therapeutics ( AIMT ) was a stock I followed and invested in and also recommended to my subscribers before the approval. The stock did double over a period of 6 months, however, there were some jittery moments right before Palforzia’s (AR101) approval with unscheduled delays and...
Montrouge, France, April 20, 2020 DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting Shareholders approve all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage...
News, Short Squeeze, Breakout and More Instantly...
DBV Technologies S.A. Company Name:
DBVT Stock Symbol:
NASDAQ Market:
DBV Technologies S.A. Website:
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutic...
Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut allergic 4-7-year-olds is on-track and recruitment is expecte...
Châtillon, France, July 29, 2024 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, toda...